Theravance Biopharma Inc (TBPH)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN, CAYMAN ISLANDS KY1-1104

Theravance Biopharma Inc focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, and central nervous system.

Data based on most recent fiscal year report
Market Cap1.302 Billion Shares Outstanding54.1 Million Avg Volume368.501 Thousand
1-Yr BETA vs S&P TR1.162 Current Ratio6.06 Quick Ratio5.79
View SEC Filings from TBPH instead.
Q2 2019 All Institutions Hedge Funds 1
To trade TBPH now:
Filers who had this stock in their top 10: 1 1 (0.1%)
13F Filers holding this stock: 93 15 (1.55%)
Aggregate 13F shares on 06/30/2019: 47.621 Million 10.542 Million
Aggregate 13F shares on 03/31/2019: 47.569 Million 10.578 Million
Percent change: 0.11% -0.35%
Funds creating new positions: 9 4
Funds Adding to an existing position: 36 3
Funds closing out their position: 16 3
Funds reducing their position: 21 4
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TBPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MITCHELL DEAN J

  • Director
0 2019-09-30 1

MAMMEN MATHAI

  • Director
0 2019-09-16 0

SULIMAN SHEHNAAZ

  • Director
0 2019-09-16 1

GLAXOSMITHKLINE PLC

  • Director
2,170,327 2019-09-10 0

WINNINGHAM RICK E CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,175,700 2019-08-20 5

HAUMANN BRETT K SVP CLIN DEV & CHIEF MED OFC

  • Officer
233,968 2019-08-20 5

PASQUALONE FRANK SVP, CHIEF COMM OPS OFFICER

  • Officer
320,759 2019-08-20 5

SHAFER BRADFORD J EVP, GEN. COUNSEL, SECRETARY

  • Officer
178,901 2019-08-20 5

WORBOYS PHILIP D SVP, TRANSLATIONAL SCIENCE

  • Officer
267,127 2019-08-20 5

HEGDE SHARATHCHANDRA S SVP, RESEARCH

  • Officer
259,900 2019-08-20 6

PITZER KENNETH R SVP, PROD STRAT & COMM PLNG

  • Officer
262,106 2019-08-20 5

SABESAN VIJAY SVP, TECHNICAL OPERATIONS

  • Officer
147,753 2019-08-20 4

BRADY ANN PRESIDENT, TBIL

  • Officer
72,184 2019-08-20 4

HINDMAN ANDREW A. SVP, CHIEF FINANCIAL OFFICER

  • Officer
50,000 2019-07-01 2

MOLINEAUX SUSAN PRESIDENT AND CEO

  • Officer
  • Director
462,188 2019-06-25 1

GALA RENEE D

  • Director
0 2019-06-10 1

ATIEH MICHAEL G

  • Director
0 2019-06-07 0

YOUNG WILLIAM D

  • Director
9,311 2019-06-01 1

O'CONNOR DONAL

  • Director
27,571 2019-05-16 2

GUNDERSON ROBERT V JR

  • Director
62,477 2019-04-30 1

MALKIEL BURTON G

  • Director
80,142 2019-04-30 1

RINGROSE PETER S

  • Director
37,999 2019-04-30 1

WHITESIDES GEORGE M

  • Director
232,613 2019-04-30 1

BROSHY ERAN

  • Director
34,571 2019-04-30 1

SMALDONE ALSUP LAURIE

  • Director
18,347 2019-04-30 1

BLUM LEONARD M SEE REMARKS

  • Officer
0 2018-05-14 0

FORE HENRIETTA

  • Director
No longer subject to file 2017-12-31 0

LEE JUNNING SR. VP, TECHNICAL OPERATIONS

  • Officer
234,071 2017-02-20 0

JONKER JEFFREY DAVID SENIOR VP, CORP. & BUS. DEV.

  • Officer
0 2014-06-03 0

THERAVANCE INC

  • 10% Owner
0 2014-05-15 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

WORBOYS PHILIP D - Officer SVP, TRANSLATIONAL SCIENCE

2019-08-20 F 2,272 $21.51 d 267,127 267,127.00 direct

BRADY ANN - Officer PRESIDENT, TBIL

2019-08-20 F 1,073 $21.51 d 72,184 72,184.00 direct

PASQUALONE FRANK - Officer SVP, CHIEF COMM OPS OFFICER

2019-08-20 F 2,335 $21.51 d 320,759 320,759.00 direct

SHAFER BRADFORD J - Officer EVP, GEN. COUNSEL, SECRETARY

2019-08-20 F 3,084 $21.51 d 178,901 178,901.00 direct

HAUMANN BRETT K - Officer SVP CLIN DEV & CHIEF MED OFC

2019-08-20 F 2,710 $21.51 d 233,968 233,968.00 direct

PITZER KENNETH R - Officer SVP, PROD STRAT & COMM PLNG

2019-08-20 F 2,272 $21.51 d 262,106 262,106.00 direct

WINNINGHAM RICK E - Director - Officer CHIEF EXECUTIVE OFFICER

2019-08-20 F 8,678 $21.51 d 1,083,133 1,175,700.00 direct

HEGDE SHARATHCHANDRA S - Officer SVP, RESEARCH

2019-08-20 F 2,272 $21.51 d 259,900 259,900.00 direct

SABESAN VIJAY - Officer SVP, TECHNICAL OPERATIONS

2019-08-20 F 1,472 $21.51 d 147,753 147,753.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments